Skip to content

Impact of low thoracic paravertebral block on intraoperative remifentanil consumption

Impact of low thoracic paravertebral block on intraoperative remifentanil consumption in patients undergoing abdominal laparoscopic surgery: a prospective historical cohort trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14915661
Enrollment
60
Registered
2025-11-18
Start date
2026-01-10
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia for patients undergoing extensive abdominal laparoscopic surgeries Surgery

Interventions

The study design is a prospective interventional trial compared to a historical cohort, conducted in a single center. The historical cohort will be constituted of patients recruited in the control gro

Sponsors

Integrated University Health and Social Services Centre of East Montreal Island
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patient from 18 to 80 years old 2. ASA 1-3 3. Laparoscopic surgery (including general surgery, gynecology, urology), a small abdominal incision (less than 5 cm) will be tolerated.

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Chronic use of opioids 3. Allergy to medication used in the trial 4. Pregnant or breastfeeding women 5. Contraindications to dexmedetomidine 6. Bradycardia, arrythmia or pacemaker, severe ventricular dysfunction

Design outcomes

Secondary

MeasureTime frame
1. Mean intraoperative blood pressure and heart rate measured using an anesthesia monitor during the intraoperative period 2. Intraoperative episodes of high blood pressure, low blood pressure, tachycardia, and bradycardia measured using an anesthesia monitor during the intraoperative 3. Requirements of rescue medications to maintain blood pressure and heart rate within the limits previously described measured using the anesthesia record during the intraoperative period 4. Intraoperative nociception level (NOL) index measured using a NOL monitor during the intraoperative period 5. Time from the end of surgery to extubation measured using the anesthesia record at one timepoint at the end of surgery 6. Total propofol consumption throughout the surgery in mg·kg?¹·h?¹ measured using the anesthesia record during the intraoperative period 7. Postoperative morphine equivalent consumption measured using the medication record at post-anesthesia care unit (PACU) stay 8. Pain scores measured using the Visual Analogue Scale (VAS) at PACU stay from arrival to discharge 9. Adverse events in PACU: hypotension, bradycardia, PONV measured using PACU records at PACU stay 10. Length of stay in PACU measured using the PACU record at PACU stay 11. Quality of Recovery (QoR) index measured using the QoR questionnaire at 24h post-op 12. Pain scores measured using the numeric rating scale (NRS) at 24h post-op 13. Hospital length of stay measured using the hospital record at discharge

Countries

Canada

Contacts

Public ContactNadia Godin
ngodin.hmr@ssss.gouv.qc.ca+1 514-295-7140

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026